| Basic Materials | 4.31% | |
|---|---|---|
| Consumer Cyclical | 7.25% | |
| Financial Services | 14.52% | |
| Real Estate | 5.57% | |
| Consumer Defensive | 17.28% | |
| Healthcare | 15.15% |
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 61.30 | 0.01 (+0.02%) | 47.69 - 62.59 | 212.0 thousand (Above Avg) |
Market data as of 4:00PM 05/17/13. Quotes are delayed by at least 15 min.
The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI EAFE Minimum Volatility Index. The fund generally invests at least 90% of its assets in securities of the underlying index or in depositary receipts representing securities in the underlying index. The underlying index begins with the MSCI EAFE Index, which is a capitalization-weighted index, and then follows a rules-based methodology to determine weights for securities in the index that seeks to minimize total risk of the MSCI EAFE Index. The fund is non-diversified.
| Open | 61.22 |
|---|---|
| Previous Close | 61.29 |
| Day's Range | 61.00 - 61.39 |
| Avg Volume (10 Day) | 119.1K |
| Total Assets | $546.02M |
| Expense Ratio | 0.34% |
| Yield (Trailing 12 Mo.) | 1.74% |
| Fund Inception | 10/18/2011 |
| Timeframe | EFAV | S&P 500 | Foreign Large Value |
|---|---|---|---|
| 1 Month | 4.23% | 1.93% | 4.44% |
| 3 Month | 10.43% | 7.18% | 3.43% |
| Year-to-Date | 14.89% | 12.74% | 8.25% |
| 1 Year | 21.15% | 16.89% | 15.79% |
| 3 Year | -- | 12.80% | 6.57% |
| 5 Year | -- | 5.21% | -0.89% |
| 10 Year | -- | 7.88% | -- |
| Since Inception | 17.41% | 10.38% | -- |
| Basic Materials | 4.31% | |
|---|---|---|
| Consumer Cyclical | 7.25% | |
| Financial Services | 14.52% | |
| Real Estate | 5.57% | |
| Consumer Defensive | 17.28% | |
| Healthcare | 15.15% |
| Utilities | 7.98% | |
|---|---|---|
| Communication Services | 11.01% | |
| Energy | 2.76% | |
| Industrials | 12.26% | |
| Technology | 1.91% |
| Company | YTD Return | % of Assets |
|---|---|---|
| Roche Holding AG | 23.65% | 1.71% |
| Novartis AG | 17.50% | 1.60% |
| Givaudan SA | -- | 1.60% |
| Reckitt Benckiser Group PLC | 14.56% | 1.54% |
| GlaxoSmithKline PLC | 20.09% | 1.51% |
| Takeda Pharmaceutical Co., Ltd. | -- | 1.51% |
| Swisscom AG | -- | 1.49% |
| Vodafone Group PLC | 21.77% | 1.49% |
| Hang Seng Bank Ltd. | 6.77% | 1.49% |
| AstraZeneca PLC | -- | 1.48% |
| Valuation | EFAV | Category Range |
|---|---|---|
| Price/Earnings | 9.83 | |
| Price/Book | 2.02 | |
| Price/Sales | 1.44 | |
| Price/Cash Flow | 9.50 | |
| Dividend Yield | 2.89 | |
| LT Earnings | 8.79 | |
| Historical Earnings | 9.22 | |
| Sales Growth | 1.96 | |
| Cash-Flow Growth | -0.69 | |
| Book-Value Growth | 3.64 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
![]() | ![]() | ![]() |

| Rating | vs Category | |
|---|---|---|
| Overall | ||
| Risk | ||
| Return |
| Beta | -- |
|---|---|
| Standard Deviation | -- |
| Alpha | -- |
| Sharpe Ratio | -- |
| Mean | -- |
| R-Squared | -- |
| Pretax Return | -- |
|---|---|
| Tax-adjusted Return | -- |
| Tax Cost Ratio | -- |
| Potential Cap Gains | 9.77% |